Eyenovia, Inc. (EYEN) Financials

EYEN Assets vs Liabilities

DateAssetsLiabilities
March 31, 2025 3.7 million 16.8 million
Dec. 31, 2024 3.7 million 16.8 million
Sept. 30, 2024 22.8 million 19.1 million
June 30, 2024 19.0 million 21.4 million

EYEN Free Cash Flow and Stock based compensation

Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2025 -6.1 million 163987
Dec. 31, 2024 -6.1 million 163987
Sept. 30, 2024 -5.9 million 452998
June 30, 2024 -8.2 million 541056

EYEN Net Income

No data available :(

EYEN Cash and Debt

Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2025 2.1 million - 1.1 million
Dec. 31, 2024 2.1 million 717504 1.3 million
Sept. 30, 2024 7.2 million 3.0 million 1.4 million
June 30, 2024 2.3 million 5.5 million 1.6 million

EYEN Shares Outstanding

Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2025 1.1 million
Dec. 31, 2024 1.5 million
Sept. 30, 2024 869479
June 30, 2024 796826

EYEN Expenses

Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2025 1 2.0 million 3.1 million 128403
Dec. 31, 2024 1 2.0 million 3.2 million 128403
Sept. 30, 2024 1623 3.5 million 3.7 million 169377
June 30, 2024 45748 4.6 million 3.8 million 263340

EYEN Cost of Revenue

Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2025 28093 3.1 million
Dec. 31, 2024 28093 3.1 million
Sept. 30, 2024 1625 132522
June 30, 2024 22625 784071

EYEN

Price: $10.56

52 week price:
0.85
124.80

Earnings Per Share: -42.65 USD

P/E Ratio: -0.37

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 305981

Market Capitalization: 80.8 million

Links: